02142cam a22003378i 450000100090000000300040000900500170001300800410003001000170007102000300008802000270011803500130014504000320015804200080019005000210019808200200021910000310023924501000027025000190037026300090038926400400039830000310043833600260046933700280049533800270052349000420055050400510059252010840064365000340172765000430176121509697OSt20260227104955.0200423s2020 flu b 001 0 eng  a 2020009451 a9780367024673q(hardback) z9780429399299q(ebook) a21509697 aKABLIBbengeKABLIBcKABLIB apcc00aRS380b.E94 202000a615.19223bEVE1 aEvens, Ronald P.,eauthor.10aBiotechnology :bthe science, the products, the government, the business /cby Ronald P. Evens. aFirst edition. a2006 1aBoca Raton, FL :bCRC Press,c2020. axix, 182p. :bill ;c25 cm atextbtxt2rdacontent aunmediatedbn2rdamedia avolumebnc2rdacarrier0 aDrugs and the pharmaceutical sciences aIncludes bibliographical references and index. a"The over-riding premise for biotechnology in this book is bringing novel products to market to substantially advance patient care and disease mitigation. Biotechnology, over its relatively brief existence of 40 years, has experienced a mercurial growth. The vast educational need for biotechnology information in this rapidly burgeoning field is a basic rationale here. However a more prominent underpinning is that, bringing biotech products to market for patient care involves success in the following four areas of engagement simultaneously - scientific advances for healthcare technologies, novel and varied products for untreated diseases, regulatory authorities, and biotech companies. Features comprehensive coverage of biotechnology science topics used in development and manufacturing, addresses all the scientific technologies within biotechnology responsible for products on the market and the pipeline, presents business issues such as marketing and sales of the products, as well as companies engaged, and how biotech business has evolved"--cProvided by publisher. 0aPharmaceutical biotechnology. 0aPharmaceutical biotechnology industry.